Cetera Advisors LLC lowered its stake in Novo Nordisk A/S by 9.8% during the third quarter, Holdings Channel reports. The firm owned 5,423 shares of the company’s stock after selling 591 shares during the period.
Category: Novo Nordisk AS
Trump Volatility Index Takes Pharma Companies on a Wild Ride 35 minutes ago
… they can help fix Obamacare, the nickname for the Affordable Care Act, which provides millions of Americans with health insurance. One of the proposed changes: repealing Obamacare’s tax on their industry. And Eli Lilly & Co. CEO Dave Ricks said …
Seaward Management Limited Partnership Holds Position in Novo Nordisk A/S
Seaward Management Limited Partnership maintained its stake in Novo Nordisk A/S during the third quarter, Holdings Channel reports. The firm owned 47,650 shares of the company’s stock at the end of the third quarter.
Novo Nordisk A/S (NVO) Receives Consensus Rating of “Hold” from Brokerages
Shares of Novo Nordisk A/S have been assigned a consensus rating of “Hold” from the seventeen brokerages that are presently covering the stock. Two equities research analysts have rated the stock with a sell recommendation, nine have issued a hold recommendation, five have given a buy recommendation and one has assigned a strong buy recommendation to the company.
Consumer Confidential: Insulin price hikes aren’t sweet – Sun, 25 Dec 2016 PST
A key feature of Republican plans to replace Obamacare is allowing market forces to boost innovation and competition among health care providers. “Unleashing the power of choice and competition is the best way to lower health care costs and improve quality,” declares House Speaker Paul Ryan in his conservative manifesto “A Better Way.”